AI-Based Clinical Decision Support System Shows Efficacy for Inherited Retinal Disease Diagnosis in Randomized Trial

A multicenter randomized trial published in Nature Medicine evaluated an AI-based clinical decision support system for diagnosing inherited retinal diseases, finding that the system meaningfully assisted clinicians in making accurate diagnoses in a controlled setting. The trial design — multicenter, randomized — is notably rigorous by clinical AI standards, giving the findings more credibility than retrospective or single-center studies. Inherited retinal diseases are a diagnostically challenging domain due to their genetic heterogeneity and the expertise required to interpret imaging and clinical data together. For developers working in medical AI, this represents a meaningful benchmark for how decision support systems can be validated for clinical deployment. The publication in Nature Medicine also signals growing acceptance of AI clinical tools in top-tier medical literature.